Patient Support & Advocacy
Health care 2020: Here’s where Congress and the states are headed
The AMA’s senior VP of advocacy offers expert insight on what physicians should expect, and advises doctors looking to make a mark with policymakers.
Saving time and lives by increased access to MAT in Pennsylvania
John Gallagher, MD, asked policymakers the hard questions about why barriers to effective treatment were allowed to persist.
Changes overdue on how substance-use disorders are covered, treated
The AMA is “laser-focused” on removing barriers to treatment for opioid-use disorder—including eliminating stigma, says the organization’s president, Patrice A. Harris, MD, MA.
ED innovation boosts access for patients with opioid-use disorder
Two emergency doctors’ efforts help ensure patients obtain appropriate follow-up medication-assisted treatment.
AMA to boost education on methadone maintenance therapy
Methadone has been used for 40 years to treat opioid-use disorder. AMA adopts policy to explore expanding access.
Fighting stigma, building a career treating substance-use disorders
Learn how AMA member Alena Balasanova, MD, is helping to fill the gaps in addiction psychiatry and medication-assisted treatment in Nebraska.
Black patients less likely to get treatment for opioid-use disorder
Financial barriers widen racial inequities in access to medication-assisted treatment for opioid-use disorder, creating a large disparity in prescriptions.
Membership Moves Medicine™
- Free access to JAMA Network™ and CME
- Save hundreds on insurance
- Fight for physicians and patient rights